Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays-Reference-Cited by-同舟云学术

Multicenter Clinical Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Using Zeus Scientific Commercial Assays

Published:2022-05-18 Issue:5 Volume:60 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Sfeir Maroun M.¹,Meece Jennifer K.²,Theel Elitza S.³^ORCID,Granger Dane³,Fritsche Thomas R.²,Steere Allen C.⁴,Branda John A.⁴^ORCID

Affiliation:

1. UConn Health, Farmington, Connecticut, USA

2. Marshfield Clinic Health System, Marshfield, Wisconsin, USA

3. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

4. Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

Abstract

Modified two-tiered testing (MTTT) algorithms for Lyme disease (LD), which involve the sequential use of orthogonal enzyme immunoassays (EIAs) without immunoblotting, are acceptable alternatives to standard two-tiered testing (STTT; EIA followed by immunoblots) provided the EIAs have been FDA-cleared for this intended use. We evaluated four Zeus Scientific LD EIAs used in two distinct MTTT algorithms for FDA review.

Funder

Zeus Scientific

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/jcm.02528-21

Reference20 articles.

1. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States

2. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease;CDC;MMWR Morb Mortal Wkly Rep,1995

3. Advances in Serodiagnostic Testing for Lyme Disease Are at Hand

4. Laboratory Diagnosis of Lyme Borreliosis

5. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Lyme serologic quantitative test indexes: High first-tier test index values predict positive second-tier result in standard and modified 2-tier Lyme testing algorithms;American Journal of Clinical Pathology;2024-09-03

2. Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease;The Journal of Infectious Diseases;2024-08-14

3. Performance of two modified two-tier algorithms for the serologic diagnosis of Lyme disease;Journal of Clinical Microbiology;2024-05-08

4. Reply to Shah, J.S.; Ramasamy, R. Target Antigens in Western and Line Immunoblots for Supporting the Diagnosis of Lyme Disease. Comment on “Porwancher et al. Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches. Pathogens 2023, 12, 1282”;Pathogens;2024-04-25

5. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM);Clinical Infectious Diseases;2024-03-05